Assembly Biosciences Inc. Revenue 2016–2025
Assembly Biosciences Inc. annual/quarterly revenue history and growth rate from 2016 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Assembly Biosciences Inc. revenue for the quarter ending March 31, 2026 was 8.2 M, a 12.80% decrease year-over-year.
- Assembly Biosciences Inc. revenue for the twelve months ending March 31, 2026 was 38.0 M, a 79.78% increase year-over-year.
- Assembly Biosciences Inc. annual revenue for 2025 was 72.3 M, a 153.52% increase from 2024.
- Assembly Biosciences Inc. annual revenue for 2024 was 28.5 M, a 298.16% increase from 2023.
- Assembly Biosciences Inc. annual revenue for 2023 was 7.2 M.
- Assembly Biosciences Inc. annual revenue for 2022 was 0.
Assembly Biosciences Inc. (ASMB) — Frequently Asked Questions
Assembly Biosciences Inc. (ASMB) is a publicly traded US company. It has a market capitalization of $247M. In fiscal 2025 it reported revenue of $72M and net income of -$6M. Explore ASMB's stock price, financial statements, earnings history, margins and key ratios below.
What is Assembly Biosciences Inc.'s market cap?
Assembly Biosciences Inc. (ASMB) has a market capitalization of $247M.
What is the ASMB stock price?
ASMB trades at $22.00 (-1.19% on the day).
How much revenue does Assembly Biosciences Inc. make?
Assembly Biosciences Inc. reported revenue of $72M in fiscal 2025.
Is ASMB profitable?
In fiscal 2025, Assembly Biosciences Inc. reported net income of -$6M.